/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Developments

Topic

Latest Stories

Butt Hurt
3.4.21, 4:30 PM EST on neoscope
China Is Administering Anal Swabs to Foreign Visitors
Rotten Luck
Updated 3.4.21, 12:22 PM EST on neoscope
People Are Catching Two COVID Strains at the Same Time
Braaaiinsss!
3.4.21, 11:19 AM EST on neoscope
CDC Updates Guidelines For Zombie Apocalypse
Baby Bust
3.3.21, 4:11 PM EST on neoscope
Experts: The United States' Dropping Birth Rate is Becoming a "Crisis"
Got Your Nose
3.3.21, 2:08 PM EST on neoscope
COVID Stole Their Smell and Taste. Now They're Getting Treatment.
Reckless
3.2.21, 5:15 PM EST on neoscope
Despite Rebounding Cases of COVID, TX to Open State "100 Percent"
Special Pass
Updated 3.2.21, 12:49 PM EST on neoscope
Expert: Vaccination Passports Could Become a "Dystopian Nightmare"
Please Focus
3.1.21, 2:56 PM EST on neoscope
Surgeon Contests Traffic Ticket While Operating on Patient
Manhunt
Updated 3.1.21, 12:09 PM EST on neoscope
Officials Hunting For Missing Person Infected With New COVID Strain
Stalling For Time
2.28.21, 11:45 AM EST on neoscope
U.S. COVID Case Decline Has Stalled, Researchers Warn
More Shots
2.25.21, 12:07 PM EST on neoscope
Moderna Testing New Vaccine Designed to Protect Against Deadly Variant
Slow Progress
2.24.21, 3:59 PM EST on neoscope
COVID Deaths Have Dropped Dramatically Since January
  • Previous
  • 1
  • ...
  • 42
  • 43
  • 44
  • ...
  • 81
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.